Moolec Confirms US Harvest And Promising Yields For Plant-Grown Products GLASO(TM) And Piggy Sooy(TM) In October
(MENAFN- ACN NewsWire) Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October
Luxembourg, Sept 5, 2024 - (ACN Newswire) -
Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today the harvest confirmation of US campaigns for genetically engineered plant-grown products GLASOTM and Piggy SooyTM during October 2024.
GLASOTM and Piggy SooyTM US Harvest Announcement
GLASOTM (gamma-linolenic acid -GLA- in safflower oil) campaign located in Idaho consists of 600 planted acres of genetically modified safflower, mainly for commercial purposes. As a result of the harvest, Moolec is expecting to produce between 300 to 400 tons of safflower seeds that contain high levels of GLA. To allocate most of the upcoming GLASOTM production, Moolec has secured an offtake agreement with a major global CPG company, targeting the US market in 2025. Following a successful and rigorous audit from Moolec's CPG customer, production is set to begin in late 2024.
The Company is also developing a broader commercial strategy to reach larger markets and clients. Moolec's GLASOTM product contains almost 3 times more GLA than conventional sources such as borage and primrose oil, making it the most concentrated GLA oil available on the market.
Piggy SooyTM (porcine myoglobin in soybean seeds) field trials are being carried out in 3 different US locations: Ohio, Missouri and Iowa. Main purposes for the campaign are product development (sampling), seed increase and gathering of environmental and regulatory data to continue Moolec's US-FDA approval pathway. The Team also projects a remarkable first open field performance for its bioengineered soybean Piggy SooyTM after recent approval for cultivation from USDA-APHIS. This has set an unprecedented milestone in biotechnology last April, with Moolec becoming the first Molecular Farming company to obtain this kind of clearance for food crops growing animal proteins in US territory.
Chief Technology Officer and Co-Founder Martín Salinas stated:
"Our commitment to scaling Moolec's Molecular Farming Technology is demonstrated by our GLASOTM campaign and the field trials of Piggy SooyTM. These efforts not only reinforce our position as pioneers in the industry but also lay the foundation for sustainable solutions in agriculture and biotechnology."
He then finished by remarking:
"One acre of Piggy SooyTM could potentially produce pork meat proteins equivalent to 10 pigs, reducing water footprint, land usage and CO2
emissions. This is a clear demonstration on how we promote environmental improvements throughout all our operations. Our aim is to heal the meat production system."
Contact Information
Press & Media
...
Investor Relations
...
Related Files
Moolec Confirms US Harvest And Promising Yields For Plant-Grown Products GLASOTM And Piggy SooyTM In October - 2024.09.05
SOURCE: Moolec Science
MENAFN05092024002725003249ID1108642008
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.